We estimate that the CEO of Xeris Biopharma Holdings, Inc. ($XERS), John Shannon, received a compensation of $5,042,584 in 2025. This is an increase of 24.1% from an estimated $3,827,109 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 23, 2026. Note that parsing errors may occur.
You can track $XERS on Quiver Quantitative's $XERS stock dashboard.
$XERS Stock Insider Trading Activity
$XERS Stock insiders have traded $XERS stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $XERS stock by insiders over the last 6 months:
- JOHN JOHNSON sold 135,400 shares for an estimated $977,019
- BETH HECHT (See Remarks) has made 0 purchases and 7 sales selling 100,002 shares for an estimated $691,944.
- JOHN PATRICK JR SHANNON (See Remarks) has made 0 purchases and 2 sales selling 48,149 shares for an estimated $349,658.
- KEVIN MCCULLOCH (See Remarks) sold 15,000 shares for an estimated $120,000
- BARBARA-JEAN ANNE BORMANN-KENNEDY sold 15,000 shares for an estimated $106,414
- JAMES ALOYSIUS BRADY sold 10,834 shares for an estimated $60,035
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$XERS Stock Hedge Fund Activity
We have seen 108 institutional investors add shares of $XERS Stock stock to their portfolio, and 117 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- D. E. SHAW & CO., INC. added 1,734,964 shares (+29.7%) to their portfolio in Q4 2025, for an estimated $13,619,467
- WELLINGTON MANAGEMENT GROUP LLP added 1,705,636 shares (+293.6%) to their portfolio in Q4 2025, for an estimated $13,389,242
- VANGUARD GROUP INC added 1,358,760 shares (+13.8%) to their portfolio in Q4 2025, for an estimated $10,666,266
- UBS GROUP AG removed 1,180,900 shares (-66.2%) from their portfolio in Q4 2025, for an estimated $9,270,065
- RENAISSANCE TECHNOLOGIES LLC removed 1,003,180 shares (-61.8%) from their portfolio in Q4 2025, for an estimated $7,874,963
- BANK OF AMERICA CORP /DE/ removed 876,952 shares (-55.0%) from their portfolio in Q4 2025, for an estimated $6,884,073
- GRANAHAN INVESTMENT MANAGEMENT, LLC added 873,236 shares (+249.4%) to their portfolio in Q4 2025, for an estimated $6,854,902
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$XERS Stock Analyst Ratings
Wall Street analysts have issued reports on $XERS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Oppenheimer issued a "Outperform" rating on 10/29/2025
To track analyst ratings and price targets for $XERS Stock, check out Quiver Quantitative's $XERS forecast page.
$XERS Stock Price Targets
Multiple analysts have issued price targets for $XERS recently. We have seen 3 analysts offer price targets for $XERS in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Brandon Folkes from HC Wainwright & Co. set a target price of $10.0 on 03/02/2026
- Glen Santangelo from Barclays set a target price of $9.0 on 12/09/2025
- Leland Gershell from Oppenheimer set a target price of $18.0 on 10/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
